Showing results (71-80 of 656) with videos related to
Sort By:
Pageof 66
Medical Oncology and Tumor Pharmacotherapy|January 1, 1984
Monoclonal antibodies to human myelomonocyte differentiation antigens in the diagnosis of acute myeloid leukemiaW Knapp, O Majdic, H Stockinger, et al.Journal of Immunology (Baltimore, Md. : 1950)|April 15, 1994
Co-ligation of CD31 and Fc gamma RII induces cytokine production in human monocytesW Chen, W Knapp, O Majdic, et al.International Journal of Cancer|May 15, 1984
M2, a novel myelomonocytic cell surface antigen and its distribution on leukemic cellsO Majdic, P Bettelheim, H Stockinger, et al.Journal of the National Cancer Institute|July 1, 1984
Exposure by desialylation of myeloid antigens on acute lymphoblastic leukemia cellsH Stockinger, O Majdic, K Liszka, et al.Journal of Biochemistry|March 1, 1996
The CDw65 monoclonal antibodies VIM-8 and VIM-11 bind to the neutral glycolipid V3FucnLc8CerB Kniep, J Peter-Katalinic, J Müthing, et al.Clinical and Experimental Immunology|April 1, 1985
Differences in the fine specificities of monoclonal (Class A) antibodies to human myeloid cellsH C Gooi, E F Hounsell, A Edwards, et al.International Journal of Cancer|March 15, 1986
Use of a cocktail of monoclonal antibodies and human complement in selective killing of acute lymphocytic leukemia cellsK Sugita, O Majdic, H Stockinger, et al.Experimental Hematology|December 1, 1985
Studies on differentiation of committed hemopoietic progenitor cells with monoclonal antibodies directed against myeloid differentiation antigensC Peschel, G Konwalinka, D Geissler, et al.The Journal of Experimental Medicine|June 1, 1984
Evidence of HLA-DR antigen biosynthesis by human keratinocytes in diseaseB Volc-Platzer, O Majdic, W Knapp, et al.Clinical and Experimental Immunology|May 1, 1990
M5, a phosphoinositol-linked human myelomonocytic activation-associated antigenS J Gadd, O Majdic, W Kasinrerk, et al.Pageof 66